GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Change In Other Working Capital

Noile-Immune Biotech (TSE:4893) Change In Other Working Capital : 円0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Change In Other Working Capital?

Noile-Immune Biotech's Change In Other Working Capital for the quarter that ended in Mar. 2024 was 円0.0 Mil. It means Noile-Immune Biotech's Other Working Capital stayed the same from Dec. 2023 to Mar. 2024 .

Noile-Immune Biotech's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was 円-5.5 Mil. It means Noile-Immune Biotech's Other Working Capital declined by 円5.5 Mil from Dec. 2022 to Dec. 2023 .


Noile-Immune Biotech Change In Other Working Capital Historical Data

The historical data trend for Noile-Immune Biotech's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Change In Other Working Capital Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
-38.96 -2.18 - -5.50

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only - - - - -

Noile-Immune Biotech Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noile-Immune Biotech Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines